Crinetics Pharmaceuticals, Inc. Operating Lease Liability
Crinetics Pharmaceuticals, Inc. (CRNX) had Operating Lease Liability of $47.19 million as of 2026-06-30, per its 10-Q filed 2026-08-03.
Financial Statements › Balance Sheet › Liabilities
us-gaap:OperatingLeaseLiability · last filed 2026-08-03
- 2026-06-30: Operating Lease, Liability $47.19M.
- 2026-03-31: Operating Lease, Liability $47.85M.
- 2025-12-31: Operating Lease, Liability $48.54M.
- 2025-09-30: Operating Lease, Liability $49.14M.
| Period end | Operating Lease, Liability |
|---|---|
| 2026-06-30 | $47.19M 10-Q · filed 2026-08-03 |
| 2026-03-31 | $47.85M 10-Q · filed 2026-05-07 |
| 2025-12-31 | $48.54M 10-K · filed 2026-02-26 |
| 2025-09-30 | $49.14M 10-Q · filed 2025-11-06 |
| 2025-06-30 | $49.94M 10-Q · filed 2025-08-07 |
| 2025-03-31 | $50.82M 10-Q · filed 2025-05-08 |
| 2024-12-31 | $51.72M 10-K · filed 2025-02-27 |
| 2024-09-30 | $52.54M 10-Q · filed 2024-11-12 |
| 2024-06-30 | $53.32M 10-Q · filed 2024-08-08 |
| 2024-03-31 | $52.50M 10-Q · filed 2024-05-09 |
| 2023-12-31 | $51.73M 10-K · filed 2024-02-28 |
| 2023-09-30 | $52.17M 10-Q · filed 2023-11-07 |
| 2023-06-30 | $2.56M 10-Q · filed 2023-08-08 |
| 2023-03-31 | $2.82M 10-Q · filed 2023-05-09 |
| 2022-12-31 | $3.08M 10-K · filed 2023-02-28 |
| 2022-09-30 | $3.32M 10-Q · filed 2022-11-14 |
| 2022-06-30 | $3.56M 10-Q · filed 2022-08-12 |
| 2022-03-31 | $3.79M 10-Q · filed 2022-05-12 |
| 2021-12-31 | $4.01M 10-K · filed 2022-03-30 |
| 2021-03-31 | $4.65M 10-Q · filed 2021-05-06 |
| 2020-12-31 | $4.85M 10-K · filed 2021-03-30 |
| 2020-09-30 | $5.04M 10-Q · filed 2020-11-06 |
| 2020-06-30 | $5.23M 10-Q · filed 2020-08-07 |
| 2020-03-31 | $5.40M 10-Q · filed 2020-05-08 |
| 2019-12-31 | $5.57M 10-K · filed 2020-03-09 |
| 2019-09-30 | $5.74M 10-Q · filed 2019-11-12 |
| 2019-06-30 | $5.90M 10-Q · filed 2019-08-13 |
| 2019-03-31 | $6.07M 10-Q · filed 2019-05-13 |